AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PATRYS LTD

0.029

0.000

Volume:- -

Turnover:5.07K

Market Cap:8.86M

PE:-1.66

High:0.029

Open:0.029

Low:0.029

Close:0.029

52wk High:0.032

52wk Low:0.019

Shares:305.58M

Float Shares:305.58M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.017

ROE:-143.39%

ROA:-57.40%

PB:12.09

PE(LYR):-1.66

Loading ...

Overview Company News Filings

Company Profile

Company Name:

PATRYS LTD

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.patrys.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PABDA.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PABDA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PABDA.AU\",,,,,undefined,":{"symbol":"PABDA.AU","market":"AU","secType":"STK","nameCN":"PATRYS LTD","latestPrice":0.029,"timestamp":1772168400000,"preClose":0.029,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"PATRYS LTD","floatShares":305583772,"shares":305583772,"eps":-0.0175,"marketStatus":"Market Closed","change":0,"latestTime":"02-27 16:00:00 AEDT","open":0.029,"high":0.029,"low":0.029,"amount":5072.183087556,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0175,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772406000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.029,"openAndCloseTimeList":[[1772146800000,1772168400000]],"volumeRatio":0,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PABDA.AU\",,,,,undefined,":{"symbol":"PABDA.AU","floatShares":305583772,"roa":"-57.40%","roe":"-143.39%","lyrEps":-0.017496,"shares":305583772,"dividePrice":0,"high":0.029,"amplitude":0,"preClose":0.029,"low":0.029,"week52Low":0.019,"pbRate":"12.09","psRate":"10.70","week52High":0.032,"institutionHeld":0,"latestPrice":0.029,"eps":-0.0175,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0175,"open":0.029,"prevYearClose":0.019,"prevWeekClose":0.029,"prevMonthClose":0.019,"prevQuarterClose":0.019},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PABDA.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-10-22","symbol":"PABDA.AU","reason":null,"defaultRemindTime":1761087600000,"announcedDate":"2025-09-08","type":"delisting","dateTimestamp":1761051600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PABDA.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.patrys.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.5263},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0138},{"period":"1month","weight":0.0259},{"period":"3month","weight":0.0551},{"period":"6month","weight":0.0911},{"period":"1year","weight":0.2078},{"period":"ytd","weight":0.0355}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.","exchange":"ASX","name":"PATRYS LTD","nameEN":"PATRYS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PABDA.AU\",market:\"AU\",,,undefined,":null}}